• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous immunoglobulin-refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream.

作者信息

Shahriari Neda, Mazori Daniel R, Merola Joseph F

机构信息

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.

出版信息

JAAD Case Rep. 2022 Dec 15;32:41-43. doi: 10.1016/j.jdcr.2022.12.002. eCollection 2023 Feb.

DOI:10.1016/j.jdcr.2022.12.002
PMID:36632562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9826807/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db2d/9826807/f60675ddd685/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db2d/9826807/aab747d47164/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db2d/9826807/f60675ddd685/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db2d/9826807/aab747d47164/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db2d/9826807/f60675ddd685/gr2.jpg

相似文献

1
Intravenous immunoglobulin-refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream.用2%托法替布乳膏成功治疗静脉注射免疫球蛋白难治性坏死性黄色肉芽肿。
JAAD Case Rep. 2022 Dec 15;32:41-43. doi: 10.1016/j.jdcr.2022.12.002. eCollection 2023 Feb.
2
Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin.静脉注射免疫球蛋白成功治疗眶周坏死性黄色肉芽肿
Case Rep Ophthalmol. 2018 Jan 17;9(1):70-75. doi: 10.1159/000485913. eCollection 2018 Jan-Apr.
3
Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin.采用体外光化学疗法和静脉注射免疫球蛋白治疗难治性坏死性黄色肉芽肿。
Dermatol Ther. 2014 Sep-Oct;27(5):268-71. doi: 10.1111/dth.12135. Epub 2014 Jun 9.
4
Systemic therapy of necrobiotic xanthogranuloma: a systematic review.坏死性黄色肉芽肿的系统性治疗：系统评价。
Orphanet J Rare Dis. 2022 Mar 24;17(1):132. doi: 10.1186/s13023-022-02291-z.
5
Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin.成功用静脉注射免疫球蛋白治疗坏死性黄色肉芽肿。
J Cutan Med Surg. 2013 Sep-Oct;17(5):347-50. doi: 10.2310/7750.2013.13012.
6
Successful multimodality treatment of recalcitrant necrobiotic xanthogranuloma using electron beam radiation and intravenous immunoglobulin.采用电子束辐射和静脉注射免疫球蛋白成功治疗顽固性坏死性黄色肉芽肿
Clin Exp Dermatol. 2016 Mar;41(2):179-82. doi: 10.1111/ced.12719. Epub 2015 Jul 24.
7
Treatment of necrobiotic xanthogranuloma - a systematic review.坏死性黄色肉芽肿的治疗——一项系统评价
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):221-235. doi: 10.1111/jdv.13786. Epub 2016 Jul 19.
8
Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.坏死性黄色肉芽肿伴单克隆丙种球蛋白血症的病理生理学。
J Intern Med. 2014 Sep;276(3):269-84. doi: 10.1111/joim.12195. Epub 2014 Feb 10.
9
First case report of pre-mortem biopsy-proven kidney involvement by necrobiotic xanthogranuloma with monoclonal gammopathy.首例生前活检证实的坏死性黄色肉芽肿伴单克隆丙种球蛋白病肾脏受累的病例报告。
J Nephrol. 2022 Jul;35(6):1753-1757. doi: 10.1007/s40620-021-01186-9. Epub 2021 Nov 5.
10
An unusual histologic variant of necrobiotic xanthogranuloma.坏死性黄色肉芽肿的一种罕见组织学变异型。
Am J Dermatopathol. 2012 Apr;34(2):e22-6. doi: 10.1097/DAD.0b013e3182222aa8.

引用本文的文献

1
Stabilization of a recalcitrant and aggressive necrobiotic xanthogranuloma with tofacitinib.托法替布治疗顽固性侵袭性坏死性黄色肉芽肿的疗效观察
An Bras Dermatol. 2025 Jul-Aug;100(4):501159. doi: 10.1016/j.abd.2025.501159. Epub 2025 Jun 28.
2
JAK inhibitors for the treatment of rheumatoid nodules.用于治疗类风湿结节的JAK抑制剂。
JAAD Case Rep. 2025 Mar 14;59:113-116. doi: 10.1016/j.jdcr.2025.02.036. eCollection 2025 May.
3
Plaques and Ulcers of Both Lower Limbs: A Quiz.双下肢斑块与溃疡：一则问答

本文引用的文献

1
The effects of blunt snout bream (Megalobrama amblycephala) IL-6 trans-signaling on immunity and iron metabolism via JAK/STAT3 pathway.团头鲂 IL-6 转导信号通过 JAK/STAT3 通路对免疫和铁代谢的影响。
Dev Comp Immunol. 2022 Jun;131:104372. doi: 10.1016/j.dci.2022.104372. Epub 2022 Feb 23.
2
A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.坏死性黄色肉芽肿的多中心横断面研究和系统评价及诊断标准的建议。
JAMA Dermatol. 2020 Mar 1;156(3):270-279. doi: 10.1001/jamadermatol.2019.4221.
3
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.
Acta Derm Venereol. 2025 Feb 6;105:adv42510. doi: 10.2340/actadv.v105.42510.
Janus 激酶抑制可诱导皮肤结节病和环状肉芽肿缓解。
J Am Acad Dermatol. 2020 Mar;82(3):612-621. doi: 10.1016/j.jaad.2019.05.098. Epub 2019 Jun 8.
4
A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.一项关于2%托法替布乳膏联合窄谱中波紫外线治疗面部白癜风的初步研究。
J Am Acad Dermatol. 2019 Aug;81(2):646-648. doi: 10.1016/j.jaad.2019.04.032. Epub 2019 Apr 19.
5
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.托法替尼治疗与皮肤结节病的分子分析。
N Engl J Med. 2018 Dec 27;379(26):2540-2546. doi: 10.1056/NEJMoa1805958.
6
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.托法替布治疗溃疡性结肠炎的诱导缓解和维持治疗。
N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910.
7
Treatment of necrobiotic xanthogranuloma - a systematic review.坏死性黄色肉芽肿的治疗——一项系统评价
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):221-235. doi: 10.1111/jdv.13786. Epub 2016 Jul 19.
8
Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.坏死性黄色肉芽肿伴单克隆丙种球蛋白血症的病理生理学。
J Intern Med. 2014 Sep;276(3):269-84. doi: 10.1111/joim.12195. Epub 2014 Feb 10.